These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9287290)
1. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. Hajjar DP; Haberland ME J Biol Chem; 1997 Sep; 272(37):22975-8. PubMed ID: 9287290 [TBL] [Abstract][Full Text] [Related]
2. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Aviram M Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155 [TBL] [Abstract][Full Text] [Related]
3. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Navab M; Berliner JA; Watson AD; Hama SY; Territo MC; Lusis AJ; Shih DM; Van Lenten BJ; Frank JS; Demer LL; Edwards PA; Fogelman AM Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):831-42. PubMed ID: 8673557 [TBL] [Abstract][Full Text] [Related]
4. The role of oxidized lipoproteins in atherogenesis. Berliner JA; Heinecke JW Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615 [TBL] [Abstract][Full Text] [Related]
5. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants. Aviram M; Fuhrman B Mol Cell Biochem; 1998 Nov; 188(1-2):149-59. PubMed ID: 9823020 [TBL] [Abstract][Full Text] [Related]
6. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446 [TBL] [Abstract][Full Text] [Related]
8. Lipoproteins and the pathogenesis of atherosclerosis. Steinberg D Circulation; 1987 Sep; 76(3):508-14. PubMed ID: 3621517 [TBL] [Abstract][Full Text] [Related]
9. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. Gu X; Kozarsky K; Krieger M J Biol Chem; 2000 Sep; 275(39):29993-30001. PubMed ID: 11001950 [TBL] [Abstract][Full Text] [Related]
10. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X. Pruzanski W; Kopilov J; Kuksis A Prostaglandins Other Lipid Mediat; 2016 Jan; 122():64-8. PubMed ID: 26711221 [TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein and scavenger receptor activities are modulated by secretory products derived from cells of the arterial wall. Aviram M Metabolism; 1989 May; 38(5):445-9. PubMed ID: 2725283 [TBL] [Abstract][Full Text] [Related]
13. [Cholesterol metabolism in the arteriosclerotic intima]. Künnert B Zentralbl Allg Pathol; 1989; 135(6):505-9. PubMed ID: 2683497 [TBL] [Abstract][Full Text] [Related]
14. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase. Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074 [TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid (Abeta40, Abeta42) binding to modified LDL accelerates macrophage foam cell formation. Schulz B; Liebisch G; Grandl M; Werner T; Barlage S; Schmitz G Biochim Biophys Acta; 2007 Oct; 1771(10):1335-44. PubMed ID: 17881287 [TBL] [Abstract][Full Text] [Related]
17. [Cellular and molecular bases of cholesterol accumulation in the vascular wall and its contribution to the progression of atherosclerotic lesion]. Llorente V; Badimon L Rev Esp Cardiol; 1998 Aug; 51(8):633-41. PubMed ID: 9780777 [TBL] [Abstract][Full Text] [Related]
18. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Kaplan M; Aviram M Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926 [TBL] [Abstract][Full Text] [Related]
19. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. Ng CJ; Wadleigh DJ; Gangopadhyay A; Hama S; Grijalva VR; Navab M; Fogelman AM; Reddy ST J Biol Chem; 2001 Nov; 276(48):44444-9. PubMed ID: 11579088 [TBL] [Abstract][Full Text] [Related]
20. [Metabolism of atherogenic lipoproteins]. Beucler I; Turpin G Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]